Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Inflammation in Alzheimer's Disease With 11C-ER176
NCT03744312Phase 2Completed
- Sponsor
- Columbia University
- Start
- Sep 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]ER176 in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Columbia University. Started Sep 2018; status: completed.
02
Drugs
[11C]ER176
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT03744312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03744312.